Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): Phase IIIb OReO/ENGOT Ov-38 trial
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Pujade-Lauraine, E.
Selle, F.
Scambia, G.
Asselain, B.
Marme, F.
Lindemann, K.
Colombo, N.
Madry, R.
Glasspool, R. M.
Dubot, C.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
